Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
During a 48-week phase 2 obesity trial, patients on weekly doses of Retatrutide (8 mg and 12 mg) had average body weight losses of 22.8% and 24.2%, respectively
Now weve entered a new era of weight loss with a groundbreaking class of medications known as GLP-1 inhibitors
PMID: 26269893
Evidence of inter organ amino acid transport by blood cells in humans
Monday - Friday 8 AM - 11:00 PM (last check-in at 10:30 PM) Saturday & Sunday 10 AM - 6 PM (last check-in at 5:30 PM) Tirzepatide works through a unique dual-action mechanism targeting GLP-1 and GIP receptors
8 Based on limited research, tirzepatide has not been shown to affect cardiovascular outcomes or reduce overall mortality compared with usual care
US$ 21.05
US$ 20.19
US$ 21.13
US$ 24.33
US$ 29.04
US$ 25.92
US$ 24.39
US$ 24.03
US$ 24.15
US$ 29.97
US$ 27.32
US$ 23.32
US$ 21.36
